Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Neoleukin Therapeutics (NLTX) SEC Filings & 10K Form

Neoleukin Therapeutics logo
$19.70 -0.33 (-1.62%)
As of 08/27/2025
Compare

Recent Neoleukin Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
4:07 PM		Commodore Capital LP (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SCHEDULE 13G/A
06/30/2025
3:02 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
11:05 AM		Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:06 AM		Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:06 AM		Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
PALEKAR ROHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:07 AM		Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Woods Robert Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:07 AM		BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:25 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:43 PM		Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
6:19 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:30 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
9:01 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form ARS
04/25/2025
8:53 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form DEF 14A
04/25/2025
8:54 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form DEFA14A
04/23/2025
7:57 PM		BlackRock, Inc. (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SCHEDULE 13G/A
04/06/2025
11:15 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form EFFECT
04/01/2025
4:22 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 424B3
03/30/2025
11:15 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form EFFECT
03/28/2025
8:27 PM		McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:28 PM		Jordan Julie (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:29 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:30 PM		Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:30 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2025
3:32 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form POS AM
03/24/2025
3:34 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/24/2025
3:14 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
4:14 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:01 PM		Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM		JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM		Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:30 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 424B3
12/16/2024
11:15 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form EFFECT
12/11/2024
3:05 PM		COMMODORE CAPITAL LP (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G
12/02/2024
4:27 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/27/2024
3:36 PM		AKKARAJU SRINIVAS (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2024
8:29 PM		McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
8:29 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neoleukin Therapeutics (Issuer)
Neurogene Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:01 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:26 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:27 PM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
11/18/2024
5:50 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM		GREAT POINT PARTNERS LLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
2:24 PM		JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
2:05 PM		Cormorant Asset Management, LP (Filed by)
Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
Form SC 13G/A
11/14/2024
5:22 AM		Neurogene Inc. (Subject)
Neoleukin Therapeutics (Subject)
Neurogene Inc. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/04/2024
6:33 AM		Neurogene Inc. (Filer)
Neoleukin Therapeutics (Filer)
Neurogene Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLTX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel